Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
302 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Fabry disease cardiomyopathy: A state-of-the-art review.
Pande S, Varzideh F, Gambardella J, et al. · Prog Cardiovasc Dis · 2025Systematic Review
- Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Nissen SE, Yeomans ND, Solomon DH, et al. · N Engl J Med · 2016Multicenter Study, Randomized Controlled Trial
- Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.
Tucker KL, Sheppard JP, Stevens R, et al. · PLoS Med · 2017Meta-Analysis, Systematic Review
- Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Banikazemi M, Bultas J, Waldek S, et al. · Ann Intern Med · 2007Multicenter Study, Randomized Controlled Trial
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, et al. · N Engl J Med · 2022Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Wallace EL, Goker-Alpan O, Wilcox WR, et al. · J Med Genet · 2024Randomized Controlled Trial, Clinical Trial, Phase III
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, et al. · N Engl J Med · 2015Comparative Study, Multicenter Study
- Editors' Note: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis.
Ganesh A, Galetta S · Neurology · 2023Meta-Analysis, Systematic Review
- The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: A systematic literature review.
Ramaswami U, West ML, Tylee K, et al. · Mol Genet Metab · 2025Systematic Review
- Aseptic meningitis and Fabry disease.
Montardi C, Gaudemer A, Zuber M, et al. · Ann Clin Transl Neurol · 2024Systematic Review
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
Hughes DA, Nicholls K, Shankar SP, et al. · J Med Genet · 2017Clinical Trial, Phase III, Randomized Controlled Trial
- Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies.
Monda E, Diana G, Graziani F, et al. · Circ Genom Precis Med · 2023Meta-Analysis, Systematic Review
- D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis.
Palaiodimou L, Stefanou MI, Bakola E, et al. · Neurology · 2022Meta-Analysis, Systematic Review
- Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
Zwanenburg ES, El Klaver C, Wisselink DD, et al. · J Clin Oncol · 2024Randomized Controlled Trial, Multicenter Study
- Lentivirus-mediated gene therapy for Fabry disease.
Khan A, Barber DL, Huang J, et al. · Nat Commun · 2021Clinical Trial, Phase I, Multicenter Study
- Hyperspectral Imaging and the Retina: Worth the Wave?
Lemmens S, Van Eijgen J, Van Keer K, et al. · Transl Vis Sci Technol · 2020Research Support, Non-U.S. Gov't, Systematic Review
- Aortic remodelling in Fabry disease.
Barbey F, Qanadli SD, Juli C, et al. · Eur Heart J · 2010Clinical Trial, Research Support, Non-U.S. Gov't
- A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4ߙweeks in adults with Fabry disease previously treated with other enzyme replacement therapies.
Holida M, Linhart A, Pisani A, et al. · J Inherit Metab Dis · 2025Clinical Trial, Phase III, Multicenter Study
- Neurology of Fabry disease.
Low M, Nicholls K, Tubridy N, et al. · Intern Med J · 2007Clinical Trial
- Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
Germain DP, Hughes DA, Nicholls K, et al. · N Engl J Med · 2016Clinical Trial, Phase III, Randomized Controlled Trial
- Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Moolenaar LR, Ali M, Aufenacker TJ, et al. · Lancet Gastroenterol Hepatol · 2026Multicenter Study, Clinical Trial, Phase III
- A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta.
Oudit GY, DasMahapatra P, Lyn N, et al. · Front Cardiovasc Med · 2024Systematic Review
- Prevalence of Fabry disease in cryptogenic stroke: a systematic review and meta-analysis with meta-regression.
Magalhães PLM, Gonçalves OR, Meira OT, et al. · J Neurol · 2025Systematic Review, Meta-Analysis
- Prognostic Significance of Late Gadolinium Enhancement in Fabry Disease-A Systematic Review and Meta-Analysis.
Ricci F, Bisaccia G, Mansour D, et al. · Am J Cardiol · 2023Meta-Analysis, Systematic Review
- Family History in Young Patients With Stroke.
Thijs V, Grittner U, Dichgans M, et al. · Stroke · 2015Clinical Trial, Multicenter Study
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.